Evidence map›Paper›PMID 37466729›Full record

ArticleCellular and molecular life sciences : CMLS2023

Comparative study of PRPH2 D2 loop mutants reveals divergent disease mechanism in rods and cones.

Larissa Ikelle, Mustafa Makia, Tylor Lewis, Ryan Crane, Mashal Kakakhel, Shannon M Conley, James R Birtley, Vadim Y Arshavsky, Muayyad R Al-Ubaidi, Muna I Naash

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. PARP inhibition preserves cone photoreceptors in rd2 retina.Acta neuropathologica communications · 2025
    Article
  3. The PRPH2 D2 Loop: Biochemical Insights and Implications in Disease.Advances in experimental medicine and biology · 2025
    Review
  4. Article
  5. Article
  6. International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Larissa Ikelle *Department of Biomedical Engineering, University of Houston, 3517 Cullen Blvd. Room 2027, Houston, TX, 77204-5060, USA.
Mustafa Makia *Department of Biomedical Engineering, University of Houston, 3517 Cullen Blvd. Room 2027, Houston, TX, 77204-5060, USA.
Tylor LewisDepartment of Ophthalmology, Duke University Medical Center, Durham, NC, USA.
Ryan CraneDepartment of Biomedical Engineering, University of Houston, 3517 Cullen Blvd. Room 2027, Houston, TX, 77204-5060, USA.
Mashal KakakhelDepartment of Biomedical Engineering, University of Houston, 3517 Cullen Blvd. Room 2027, Houston, TX, 77204-5060, USA.
Shannon M ConleyDepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
James R BirtleyEpsilogen Ltd, Hammersmith, London, W6 9RH, UK.
Vadim Y ArshavskyDepartment of Ophthalmology, Duke University Medical Center, Durham, NC, USA.
Muayyad R Al-UbaidiDepartment of Biomedical Engineering, University of Houston, 3517 Cullen Blvd. Room 2027, Houston, TX, 77204-5060, USA. malubaid@central.uh.edu.ORCID http://orcid.org/0000-0002-4914-350X
Muna I NaashDepartment of Biomedical Engineering, University of Houston, 3517 Cullen Blvd. Room 2027, Houston, TX, 77204-5060, USA. mnaash@central.uh.edu.ORCID http://orcid.org/0000-0002-6534-5144
University of Houston · USDuke Medical Center · USUniversity of Oklahoma Health Sciences Center · US

Funding

VISION RESEARCHP30EY005722 · NEI · DUKE UNIVERSITY · PI W Daniel Stamer · 1985 to 2026
$19.3M
Supplement for: Mechanism of Photoreceptor Cell Degeneration in Animal Models of Retinal DiseasesR01EY010609 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI MUAYYAD R AL-UBAIDI, Muna I. Naash · 1995 to 2026
$11.0M
Compacted DNA Nanoparticles for Ocular TherapyR01EY018656 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI AL-UBAIDI, MUAYYAD R, NAASH, MUNA I. · 2008 to 2021
$5.6M
Mechanisms of photoreceptor disc maturationR01EY030451 · NEI · DUKE UNIVERSITY · PI ARSHAVSKY, VADIM Y · 2020 to 2024
$2.4M
The role of IGF-1 signaling in vascular smooth muscle cells in age-related vascular cognitive impairment and dementiaR01AG070915 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CONLEY, SHANNON M · 2021 to 2025
$1.8M
The role of ADAM9 in retinal health and diseaseR00EY033763 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Tylor Robert Lewis · 2024 to 2026
$747k
Mechanism of photoreceptor cell degeneration in animal models of retinal diseasesR56EY010609 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI NAASH, MUNA I. · 2008 to 2008
$479k
The role of ADAM9 in retinal health and diseaseK99EY033763 · NEI · DUKE UNIVERSITY · PI LEWIS, TYLOR ROBERT · 2022 to 2023
$252k
The differential behavior of Prph2/Rom1 in rods and cone contributes to Prph2-associated disease heterogeneityF31EY033216 · NEI · UNIVERSITY OF HOUSTON · PI IKELLE, LARISSA · 2021 to 2025
$208k
PHOTORECEPTORSR55EY010609 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NAASH, MUNA I · 1994 to 1994
–
NEI NIH HHS EY005722NEI NIH HHS EY010609NEI NIH HHS EY018656NEI NIH HHS EY030451NEI NIH HHS EY033216NEI NIH HHS EY033763NEI NIH HHS F31 EY033216NEI NIH HHS K99 EY033763NEI NIH HHS P30 EY005722NEI NIH HHS R00 EY033763NEI NIH HHS R01 EY010609NEI NIH HHS R01 EY018656NEI NIH HHS R01 EY030451NEI NIH HHS R56 EY010609NIA NIH HHS R01 AG070915
6 · The paper itself

Abstract

Mutations in the photoreceptor-specific tetraspanin gene peripherin-2 (PRPH2) lead to widely varying forms of retinal degeneration ranging from retinitis pigmentosa to macular dystrophy. Both inter- and intra-familial phenotypic heterogeneity has led to much interest in uncovering the complex pathogenic mechanisms of PRPH2-associated disease. Majority of disease-causing mutations in PRPH2 reside in the second intradiscal loop, wherein seven cysteines control protein folding and oligomerization. Here, we utilize knockin models to evaluate the role of three D2 loop cysteine mutants (Y141C, C213Y and C150S), alone or in combination. We elucidated how these mutations affect PRPH2 properties, including oligomerization and subcellular localization, and contribute to disease processes. Results from our structural, functional and molecular studies revealed that, in contrast to our understanding from prior investigations, rods are highly affected by PRPH2 mutations interfering with oligomerization and not merely by the haploinsufficiency associated with these mutations. On the other hand, cones are less affected by the toxicity of the mutant protein and significantly reduced protein levels, suggesting that knockdown therapeutic strategies may sustain cone functionality for a longer period. This observation provides useful data to guide and simplify the current development of effective therapeutic approaches for PRPH2-associated diseases that combine knockdown with high levels of gene supplementation needed to generate prolonged rod improvement.

Indexed as

Macular DegenerationRetinal DegenerationRetinitis PigmentosaHumansMutationRetinal Cone Photoreceptor CellsTetraspaninsTetraspaninsPattern dystrophyPeripherin-2Retinal degenerationRetinitis pigmentosaROM1Tetraspanin

Identifiers

PMID37466729
PMCPMC10356684
OpenAlexW4384662855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.